Skip to main content

A child sits with his mother

Two families reflect on their malaria vaccine journey

Catching up with the first children to receive the RTS,S malaria vaccine in Malawi, one year later.

PATH welcomes landmark financing agreement for GSK's malaria vaccine

PATH congratulates Gavi, GSK, and MedAccess for joining forces to help ensure an ongoing supply of the first malaria vaccine, RTS,S/AS01_E.

GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

Bharat Biotech will produce the antigen for RTS,S/AS01 following technology transfer.

We’re ready to beat malaria. Are you?

Put your knowledge to the test with a three-question quiz. Ready to begin?

Home

Latest

PATH welcomes remarkable results from clinical trial combining RTS,S/AS01 malaria vaccine with Seasonal Malaria Chemoprevention

Frequently Asked Questions (FAQs): RTS,S/AS01 for seasonal use

PATH welcomes landmark financing agreement for GSK’s malaria vaccine

GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

Frequently Asked Questions (FAQs): Product Transfer for the RTS,S/AS01 Malaria Vaccine

Milestone study identifies immune markers that may help predict success of vaccination with RTS,S/AS01 malaria vaccine

PATH receives new five-year contract from USAID for malaria vaccine research and development

A child sits with his mother

Two families reflect on their malaria vaccine journey

PATH continues exciting partnership with the GHIT Fund to develop a next-generation malaria vaccine

Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein

Journal article

RTS,S Malaria Vaccine: 2019 Partnership Award Honoree

PATH and partners receive award for development of world’s first malaria vaccine

Twitter @MalariaVaccine

RT @PAlonsoMalaria: Malaria: a problem to be solved and a time to be bold | Nature Medicine ⁦@WHO⁩ ⁦@MoetiTshidi⁩ ⁦@rajpanjabi⁩ ⁦… https://t.co/oEJJ0f8Wx2

17 Sep 2021

RT @prasannaj77: Interested in human immunology of malaria and clinical trials? The Jagannathan Lab at Stanford is recruiting post-… https://t.co/OT6eHpQM89

16 Sep 2021

RT @BillGates: This news is not surprising to many of us who work in global health. But there are things the world can do to help… https://t.co/N9rLUTTfaH

13 Sep 2021

RT @JHMRImalaria: #CallingAllScientists Please Save the Date, Nov 12 for the Future of Malaria Research symposium. And submit abstrac… https://t.co/ZYTbJfnGwh

10 Sep 2021

RT @GlobalFund: Working together @GlobalFund partnership has saved 44 MILLION lives since 2002. But for the first time in Global Fu… https://t.co/5PfU5KhrGJ

9 Sep 2021

RT @NatureMedicine: ⭐ Research Highlight: A monoclonal antibody can prevent #malaria, according to early clinical data published in… https://t.co/otuc2skfoc

7 Sep 2021

New article in @Nature_NPJ shows that certain antibodies are associated with protection against #malaria infection: https://t.co/USpCambqrI

3 Sep 2021

RT @ipsnews: In the midst of the turmoil caused by the pandemic, it’s gratifying to see work continuing in Africa to find new wa… https://t.co/qny2F854ir

2 Sep 2021

RT @PAlonsoMalaria: A new use case of RTS,S vaccine for areas with #malaria seasonality. A step closer to a potential #WHO recommendati… https://t.co/bDmEbXVb6X

30 Aug 2021

RT @WHOAFRO: New science shows severe #malaria & death among young children dramatically reduced through use of the 1st #malaria… https://t.co/ztYMFb4br3

27 Aug 2021

Drug and vaccine combo could cut child #malaria deaths by 70 per cent, study shows. Director of @PATHtweets Malaria… https://t.co/0B7sqS8bic

26 Aug 2021

RT @LSHTM: In 2019, #malaria caused around 409,000 deaths, mostly in children under five. With researchers in Mali and Burkin… https://t.co/jxBXO2dFmT

26 Aug 2021